Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Chu‐Long Xie is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for pulmonary and mediastinal diseases. His major contributions lie in comparing and validating robotic-assisted approaches against traditional video-assisted methods for lung cancer treatment. In his landmark 2023 study (15 citations), Dr. Xie demonstrated that robotic lobectomy offers superior short-term outcomes over video-assisted lobectomy for pulmonary neoplasms, providing critical evidence for the adoption of robotic platforms. He further extended this work to segmentectomy for small pulmonary nodules, using propensity score-matching to confirm robotic advantages (14 citations). Dr. Xie has also systematically defined the learning curve for robotic portal segmentectomy through a prospective observational study (5 citations), offering essential guidance for surgeons adopting this technology. Most recently, his 2024 investigation into robotic portal resection for mediastinal tumours (2 citations) underscores the versatility and feasibility of robotic approaches across thoracic procedures. By rigorously comparing surgical modalities and establishing training benchmarks, Dr. Xie’s work directly shapes clinical decision-making and surgical education, positioning him as a leading voice in the evolution of robotic thoracic surgery.